A Favorable Macroeconomic Backdrop For Big Pharma
Publicado en
According to BCA Research’s US Equity Strategy and US Political Strategy services, the macro backdrop is favorable for Pharma. as it tends to outperform the market during the slowdown and contraction stages of the business cycle. Q1-2023 GDP came in weaker…
¿Interesado en leer el Daily Insight completo?
Lee el análisis completo con acceso instantáneo.
Investigación BCA | Essentials
Concise macro insight that cuts through daily noise, helping clients stay informed on what matters in markets, why it matters, and how to talk about it, without spending hours reading research.
Mantente conectado con BCA
Recibe nuestros últimos eventos y análisis de investigación directamente en tu correo.